Works matching Cyclosporine

Results: 5000

The protective effect of vildagliptin in chronic experimental cyclosporine A-induced hepatotoxicity.

Published in:

Canadian Journal of Physiology & Pharmacology, 2016, v. 94, n. 3, p. 251, doi. 10.1139/cjpp-2015-0336

By:

El-Sherbeeny, Nagla A.;
Nader, Manar A.

Publication type:

Article

Cyclosporine Metabolites' Metabolic Ratios May Be Markers of Cardiovascular Disease in Kidney Transplant Recipients Treated with Cyclosporine A-Based Immunosuppression Regimens.

Published in:

Cardiovascular Toxicology, 2019, v. 19, n. 3, p. 255, doi. 10.1007/s12012-018-9492-9

By:

Hryniewiecka, Ewa;
Żegarska, Jolanta;
Żochowska, Dorota;
Samborowska, Emilia;
Jaźwiec, Radosław;
Kosieradzki, Maciej;
Nazarewski, Sławomir;
Dadlez, Michał;
Pączek, Leszek

Publication type:

Article

The upregulation of heat shock protein 47 in human gingival fibroblasts stimulated with cyclosporine A.

Published in:

Journal of Periodontal Research, 2010, v. 45, n. 3, p. 317, doi. 10.1111/j.1600-0765.2009.01238.x

By:

Chang, T.‐Y.;
Tsai, C.‐H.;
Chang, Y.‐C.

Publication type:

Article

Simvastatin therapy in cyclosporine A-induced alveolar bone loss in rats.

Published in:

Journal of Periodontal Research, 2009, v. 44, n. 4, p. 479, doi. 10.1111/j.1600-0765.2008.01143.x

By:

Nassar, P. O.;
Nassar, C. A.;
Guimarães, M. R.;
Aquino, S. G.;
Andia, D. C.;
Muscara, M. N.;
Spolidorio, D. M. P.;
Rossa Jr, C.;
Spolidorio, L. C.

Publication type:

Article

The upregulation of cystatin C in human gingival fibroblasts stimulated with cyclosporine A.

Published in:

Journal of Periodontal Research, 2009, v. 44, n. 4, p. 459, doi. 10.1111/j.1600-0765.2008.01147.x

By:

Tsai, C.‐H.;
Yang, S.‐F.;
Huang, F.‐M.;
Chang, Y.‐C.

Publication type:

Article

Expression and bioactivities of endothelin-1 in gingiva during cyclosporine A treatment.

Published in:

Journal of Periodontal Research, 2009, v. 44, n. 1, p. 35, doi. 10.1111/j.1600-0765.2007.01058.x

By:

Chin, Y‐T.;
Tu, H‐P.;
Chen, Y‐T.;
Dai, N‐T.;
Shen, E‐C.;
Chiang, C‐Y.;
Fu, M. M‐J.;
Fu, E.

Publication type:

Article

Transient hyperphosphatasemia in three pediatric patients treated with cyclosporine.

Published in:

Pediatrics International, 2016, v. 58, n. 5, p. 429, doi. 10.1111/ped.12923

By:

Mori, Takeshi;
Tanaka, Ryojiro;
Nishida, Kosuke;
Yamamoto, Nobuyuki;
Hayakawa, Akira;
Nishimura, Noriyuki;
Nozu, Kandai;
Iijima, Kazumoto

Publication type:

Article

Medical Management of Canine Chronic Ulcerative Stomatitis Using Cyclosporine and Metronidazole.

Published in:

Journal of Veterinary Dentistry, 2023, v. 40, n. 2, p. 109, doi. 10.1177/08987564221148755

By:

Ford, Kimberly R.;
Anderson, Jamie G.;
Stapleton, Barbara L.;
Murphy, Brian G.;
Kumar, T. K. Santosh;
Archer, Todd;
Mackin, Andrew J.;
Wills, Robert W.

Publication type:

Article

Dramatic Deep and Durable Remission of Acute Fulminant Ulcerative Colitis Achieved with Cyclosporine in a Patient Who Failed the Induction Intravenous Phase of Cyclosporine.

Published in:

Case Reports in Gastroenterology, 2021, v. 15, n. 1, p. 147, doi. 10.1159/000512426

By:

Philippou, Alicia;
Rizvi, Anam;
Steinlauf, Adam

Publication type:

Article

Kronik Vernal Keratokonjonktivitli Olgularda Topikal Siklosporin A %0.05 Tedavisi Etkinliğinin Araştırılması.

Published in:

Journal of Glaucoma-Cataract / Glokom-Katarakt, 2014, v. 9, n. 1, p. 14

By:

KALDIRIM, Havva;
YAZGAN, Serpil;
ÇELİK, Hacı Uğur;
ÇEKİÇ, Osman

Publication type:

Article

Clinical efficacy of 0.1% cyclosporine A in dry eye patients with inadequate responses to 0.05% cyclosporine A: a switching, prospective, open-label, multicenter study.

Published in:

BMC Ophthalmology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12886-025-03862-x

By:

Yoon, Sook Hyun;
Kim, Eun Chul;
You, In-Cheon;
Choi, Chul Young;
Kim, Jae Yong;
Song, Jong Suk;
Hyon, Joon Young;
Kim, Hong Kyun;
Seo, Kyoung Yul

Publication type:

Article

Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: A randomized, placebo-controlled, double-blind, parallel clinical trial.

Published in:

Dermatologic Therapy, 2015, v. 28, n. 1, p. 44, doi. 10.1111/dth.12163

By:

Jin, Sang‐Yoon;
Lim, Won‐Suk;
Sung, Nam Hee;
Cheong, Kyung Ah;
Lee, Ai‐Young

Publication type:

Article

A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye.

Published in:

Clinical Ophthalmology, 2023, v. 17, p. 2181, doi. 10.2147/OPTH.S419600

By:

Hovanesian, John;
Chester, Thomas;
Sorenson, Robert C

Publication type:

Article

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children.

Published in:

Clinical Ophthalmology, 2022, v. 16, p. 3589, doi. 10.2147/OPTH.S370414

By:

Bourcier, Tristan;
Dory, Anne;
Dormegny, Lea;
Alcazar, Joffrey;
Gaucher, David;
Sauer, Arnaud

Publication type:

Article

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments.

Published in:

Clinical Ophthalmology, 2020, v. 14, p. 4187, doi. 10.2147/OPTH.S279051

By:

Periman, Laura M;
Mah, Francis S;
Karpecki, Paul M

Publication type:

Article

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.

Published in:

Clinical Ophthalmology, 2020, v. 14, p. 2747, doi. 10.2147/OPTH.S259331

By:

Burade, Vinod;
Zalawadia, Rishit;
Patel, Alpesh;
Ogundele, Abayomi

Publication type:

Article

Well-tolerated oral cyclosporine in a case of hypersensitivity to parenteral cyclosporine in postallogeneic bone marrow transplantation.

Published in:

Indian Journal of Pharmacology, 2018, v. 50, n. 2, p. 94, doi. 10.4103/ijp.IJP_99_18

By:

Moeinian, Mahsa;
Sotoude, Hamed;
Mohebbi, Zahra;
Asadollahi-Amin, Ali;
Mozafari, Rambod

Publication type:

Article

Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine–sirolimus interaction.

Published in:

Kidney International, 2006, v. 70, n. 6, p. 1019, doi. 10.1038/sj.ki.5001649

By:

Anglicheau, D.;
Pallet, N.;
Rabant, M.;
Marquet, P.;
Cassinat, B.;
Méria, P.;
Beaune, P.;
Legendre, C.;
Thervet, E.

Publication type:

Article

Cyclosporine-A in severe chronic urticaria: the option for long-term therapy.

Published in:

Allergy, 2010, v. 65, n. 11, p. 1478, doi. 10.1111/j.1398-9995.2010.02419.x

By:

Kessel, A.;
Toubi, E.

Publication type:

Article

A case of cyclosporine-induced optic neuropathy with a normal therapeutic level of cyclosporine.

Published in:

Japanese Journal of Ophthalmology, 2010, v. 54, n. 1, p. 102, doi. 10.1007/s10384-009-0747-7

By:

Akagi, Tadamichi;
Manabe, Shinichi;
Ishigooka, Hitoshi

Publication type:

Article

Benefits of cyclosporine absorption profiling in nephrotic syndrome: Preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.

Published in:

Nephrology, 2007, v. 12, n. 2, p. 197, doi. 10.1111/j.1440-1797.2007.00773.x

By:

Takeda, Asami;
Horike, Keiji;
Onoda, Hiroshi;
Ohtsuka, Yasuhiro;
Yoshida, Astuhiro;
Uchida, Kazuharu;
Morozumi, Kunio

Publication type:

Article

Oral Microemulsion Cyclosporine in the Treatment of Steroid-Refractory Attacks of Ulcerative and Indeterminate Colitis.

Published in:

Scandinavian Journal of Gastroenterology, 2001, v. 36, n. 6, p. 610, doi. 10.1080/003655201750163051

By:

Navazo, L.;
Salata, H.;
Morales, S.;
Dorta, Ma C.;
Pérez, F.;
de las Casas, D.;
Avilés, J.

Publication type:

Article

Comparison of the Effect of and Compliance With Cyclosporine 0.1% After Various Pretreatments in Dry Eye Disease.

Published in:

Journal of Ophthalmology, 2025, v. 2025, p. 1, doi. 10.1155/joph/6744482

By:

Jee, Donghyun;
Han, Su Yeon;
Kim, Hyun Seung;
Kim, Eun Chul;
Oliverio, Giovanni William

Publication type:

Article

Safety and efficacy of sirolimus combined with cyclosporine in primary membranous nephropathy: a randomized controlled trial.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04173-0

By:

Wang, Fang;
Yang, Chao;
Shu, Yue;
Lin, Cai-xia;
Yao, Yao;
Li, Yue;
Zhang, Yi-miao;
Wang, Xin;
Meng, Li-qiang;
Cheng, Xu-yang;
Liu, Gang;
Zhao, Ming-hui;
Cui, Zhao

Publication type:

Article

Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 12, p. 1923, doi. 10.1007/s00228-024-03750-1

By:

Suilik, Husam Abu;
Al-shammari, Ali Saad;
Soliman, Youssef;
Suilik, Mohamed Abu;
Naeim, Kamal A.;
Nawlo, Ahmad;
Abuelazm, Mohamed

Publication type:

Article

A decision support tool to find the best cyclosporine dose when switching from intravenous to oral route in pediatric stem cell transplant patients.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 10, p. 1409, doi. 10.1007/s00228-020-02918-9

By:

Leclerc, Vincent;
Bleyzac, Nathalie;
Ceraulo, Antony;
Bertrand, Yves;
Ducher, Michel

Publication type:

Article

Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 6, p. 1321, doi. 10.1007/s00228-013-1471-2

By:

Nara, Miho;
Takahashi, Naoto;
Miura, Masatomo;
Niioka, Takenori;
Kagaya, Hideaki;
Fujishima, Naohito;
Saitoh, Hirobumi;
Kameoka, Yoshihiro;
Tagawa, Hiroyuki;
Hirokawa, Makoto;
Sawada, Kenichi

Publication type:

Article

Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1517, doi. 10.1007/s00228-012-1275-9

By:

Eljebari, Hanene;
Gaies, Emna;
Fradj, Nadia;
Jebabli, Nadia;
Salouage, Issam;
Trabelsi, Sameh;
Lakhal, Mohamed;
Klouz, Anis

Publication type:

Article

Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 12, p. 1177, doi. 10.1007/s00228-010-0902-6

By:

Penninga, Luit;
Møller, Christian;
Gustafsson, Finn;
Steinbrüchel, Daniel;
Gluud, Christian

Publication type:

Article

Prediction of cyclosporine A blood levels: an application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy.

Published in:

European Journal of Clinical Pharmacology, 2008, v. 64, n. 8, p. 807, doi. 10.1007/s00228-008-0490-x

By:

Gören, Sezer;
Karahoca, Adem;
Onat, Filiz Y.;
Gören, M. Zafer

Publication type:

Article

Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 5, p. 361, doi. 10.1007/s00228-006-0109-z

By:

Kovarik, John M.;
Noe, Adele;
Yibin Wang;
Mueller, Irene;
DeNucci, Gilberto;
Schmouder, Robert L.

Publication type:

Article

Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 3, doi. 10.1007/s00228-005-0064-0

By:

El-Husseini, Amr;
El-Basuony, Fathy;
Mahmoud, Ihab;
Donia, Ahmed;
Sheashaa, Hussein;
Sabry, Alaa;
Hassan, Nabil;
Sayed-Ahmad, Nagy;
Sobh, Mohamed

Publication type:

Article

Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Published in:

European Journal of Clinical Pharmacology, 2004, v. 60, n. 6, p. 389, doi. 10.1007/s00228-004-0774-8

By:

Johnston, Atholl;
Belitsky, Philip;
Frei, Ulrich;
Horvath, John;
Hoyer, Peter;
Helderman, J. Harold;
Oellerich, Michael;
Pollard, Stephen;
Riad, Hany;
Rigotti, Paolo;
Keown, Paul;
Nashan, Björn

Publication type:

Article

Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C.

Published in:

Basic Research in Cardiology, 2002, v. 97, n. 2, p. 125, doi. 10.1007/s003950200002

By:

Sindermann, Jürgen R.;
Skaletz-Rorowski, Adriane;
Bartels, Anke;
Hohage, Helge;
Plenz, Gabriele;
Schmidt, Annette;
Breithardt, Günter

Publication type:

Article

Cyclosporine Treatment Increases the ACE/ACE2 Ratio in Adipose Tissue and Aorta.

Published in:

Experimed, 2023, v. 13, n. 2, p. 93, doi. 10.26650/experimed.1291728

By:

Darilmaz, Samed Emre;
Bingul, Ilknur;
Soluk-Tekkesin, Merva;
Demir, Nergis;
Bekpinar, Seldag

Publication type:

Article

Successful Treatment of Hailey-Hailey Disease with Systemic Cyclosporine: Case Report.

Published in:

Turkiye Klinikleri Journal of Dermatology, 2017, v. 27, n. 2, p. 101, doi. 10.5336/dermato.2016-53980

By:

ŞAHIN, Gökhan;
ŞENTÜRK, Nilgün;
KOÇ ŞAHİN, Seda

Publication type:

Article

Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.

Published in:

Pediatric Allergy & Immunology, 2010, v. 21, n. 2, p. 330, doi. 10.1111/j.1399-3038.2009.00948.x

By:

Tesse, Riccardina;
Spadavecchia, Laura;
Fanelli, Pietro;
Rizzo, Giovanna;
Procoli, Ugo;
Brunetti, Luigia;
Cardinale, Fabio;
Miniello, Vito L.;
Bellizzi, Mario;
Armenio, Lucio

Publication type:

Article

Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.

Published in:

Pediatric Allergy & Immunology, 2006, v. 17, n. 7, p. 527, doi. 10.1111/j.1399-3038.2006.00427.x

By:

Spadavecchia, Laura;
Fanelli, Pietro;
Tesse, Riccardina;
Brunetti, Luigia;
Cardinale, Fabio;
Bellizzi, Mario;
Rizzo, Giovanna;
Procoli, Ugo;
Bellizzi, Gianfranco;
Armenio, Lucio

Publication type:

Article

Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis.

Published in:

Life (2075-1729), 2023, v. 13, n. 9, p. 1873, doi. 10.3390/life13091873

By:

Frątczak, Aleksandra;
Miziołek, Bartosz;
Łupicka-Słowik, Agnieszka;
Sieńczyk, Marcin;
Polak, Karina;
Bergler-Czop, Beata

Publication type:

Article

Combination therapy of cyclosporine and prednisolone in a dog with systemic lupus erythematosus.

Published in:

Korean Journal of Veterinary Research, 2016, v. 56, n. 1, p. 47, doi. 10.14405/kjvr.2016.56.1.47

By:

Yeon-Hee Kim;
Min-Hee Kang;
Hee-Myung Park

Publication type:

Article

Lack of effects on lymphocyte function from chronic topical ocular cyclosporine medication: a prospective study.

Published in:

Veterinary Ophthalmology, 2010, v. 13, n. 5, p. 315, doi. 10.1111/j.1463-5224.2010.00818.x

By:

Williams, David L.

Publication type:

Article

Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases.

Published in:

Veterinary Ophthalmology, 2009, v. 12, n. 2, p. 132, doi. 10.1111/j.1463-5224.2008.00679.x

By:

Spiess, Amelie K.;
Sapienza, John S.;
Mayordomo, Aloma

Publication type:

Article

Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren's Syndrome.

Published in:

Ocular Immunology & Inflammation, 2023, v. 31, n. 8, p. 1662, doi. 10.1080/09273948.2022.2094812

By:

Gao, Mingjun;
Zhao, Lin;
Liang, Ran;
Zhu, Qing;
Zhao, Qi;
Kong, Xiaodan

Publication type:

Article

A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.

Published in:

Ocular Immunology & Inflammation, 2023, v. 31, n. 2, p. 462, doi. 10.1080/09273948.2022.2028293

By:

Nakayama, Makiko;
Okada, Annabelle A;
Hayashi, Isami;
Ando, Yoshimasa;
Watanabe, Takayo;
Keino, Hiroshi

Publication type:

Article

Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.

Published in:

Ocular Immunology & Inflammation, 2022, v. 30, n. 5, p. 1083, doi. 10.1080/09273948.2020.1867870

By:

Malhotra, Chintan;
Singh, Himanshi;
Jain, Arun Kumar;
Gupta, Amit;
Ram, Jagat

Publication type:

Article

Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review.

Published in:

Ocular Immunology & Inflammation, 2021, v. 29, n. 7/8, p. 1606, doi. 10.1080/09273948.2020.1757121

By:

Tong, Louis;
Sun, Chi Chin;
Yoon, Kyung Chul;
Lim Bon Siong, Ruben;
Puangsricharern, Vilavun;
Baudouin, Christophe

Publication type:

Article

Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.

Published in:

European Journal of Pediatrics, 2013, v. 172, n. 3, p. 351, doi. 10.1007/s00431-012-1893-3

By:

El-Khalawany, Mohamed;
Hassan, Hatem;
Shaaban, Dalia;
Ghonaim, Noha;
Eassa, Bayoumi

Publication type:

Article

Case report: Cyclosporine A-induced extrapyramidal syndrome following hematopoietic stem cell transplantation.

Published in:

Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1140732

By:

Al-Amrani, Fatema;
Al Rawas, Abdulhakeem;
Al-Ajmi, Eiman;
Al Futaisi, Amna

Publication type:

Article

Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies.

Published in:

Clinical Pharmacology, 2020, v. 12, p. 83, doi. 10.2147/CPAA.S255789

By:

Li, Yan;
Palmisano, Maria;
Sun, Duxin;
Zhou, Simon

Publication type:

Article

A Patient with Refractory Psoriasis Who Developed Sebaceous Carcinoma on the Neck during Cyclosporine Therapy and Showed Rapid Progression.

Published in:

Case Reports in Dermatology, 2016, v. 8, n. 2, p. 136, doi. 10.1159/000446342

By:

Shima, Tomoko;
Yamamoto, Yuki;
Okuhira, Hisako;
Mikita, Naoya;
Furukawa, Fukumi

Publication type:

Article